This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Modality Solutions, LLC, a privately-held company that delivers integrated cold chain management solutions for highly-regulated public health and life science industries, is pleased to announce its sponsorship and roundtable leadership at the 17th Annual World Vaccine Congress, April 10-12 at the Grand Hyatt in Washington, DC. The Congress promotes research, development and strategic partnering for the global vaccine industry.
Daniel Littlefield, Principal at Modality Solutions, will lead an interactive roundtable discussion on WVC Day 1 at 11:20 a.m. Titled: Managing Your Cold Chain – Lessons Learned from the Ebola Clinical Trials. Littlefield will cover the topic of: Are you effectively managing temperature requirements in your clinical trials in Zone 4 climate zones? The discussion will include the management of multiple temperature ranges from <-60 °C to 2 °C to 8 °C, the transport and storage with minimal infrastructure to remote depots and clinical trial sites and compliance by partnering with the local regulatory authorities.
“I invite Congress attendees to join my interactive roundtable,” said Modality Solutions Principal, Daniel Littlefield. “Come learn practical solutions for the real-world challenges that led to a flawless execution of the STRIVE Ebola clinical trial in sub-Saharan Africa with zero temperature excursions.”
“Our sponsorship and participation in the WVA supports our continued commitment to work with vaccine experts from top pharmaceutical and biotechnology companies worldwide,” said Modality Solutions President Gary Hutchinson. “The Congress will cover some of the crucial technological developments that are changing how vaccines are researched, manufactured and distributed.”
The World Vaccine Congress Washington is well-established as the leading event on vaccines each year. Now in its seventeenth year, attendees are guaranteed the best experience on-site ever. The Congress will cover the crucial topics which are affecting the whole sector. Leadership anticipates more than 700 senior vaccine executives will take advantage of the World Vaccine Congress as well as the eight co-located streams on Immune Profiling, Cancer & Immunotherapy, Influenza & Respiratory, Clinical Trials, Emerging Diseases, Partnerships, Veterinary Vaccines, and Bioprocessing & Manufacturing.
For more information and to register for the 2017 World Vaccine Congress, visit https://goo.gl/5I6XtF.
